Transcatheter Aortic Valve Replacement for Aortic Valve Infective Endocarditis: A Systematic Review and Call for Action - Cardiology and Therapy
Source : https://link.springer.com/article/10.1007/s40119-023-00314-9
We aimed to systematically analyze the literature on the use of transcatheter aortic valve replacement (TAVR) to treat active aortic valve infective endocarditis (AV-IE). Surgery is declined in one-third of...
Share
Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome Analysis - American Journal of Cardiovascular Drugs
Source : https://link.springer.com/article/10.1007/s40256-023-00578-5
Background Dapagliflozin and empagliflozin have shown clinical benefits in patients with heart failure (HF). Their comparative monetary value remains undetermined, and we therefore sought to compare the cost-per-outcome implications of...
Share
Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37062866/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Share
Tumor necrosis factor-α mediates inflammation-induced early-stage left ventricular systolic dysfunction
Source : https://journals.lww.com/cardiovascularpharm/Abstract/9900/Tumor_necrosis_factor___mediates.172.aspx
We have previously shown that rats with collagen-induced arthritis (CIA) have systemic inflammation, LV diastolic dysfunction, and that increased circulating TNF-α contributes to inflammation-induced HFpEF pathogenesis, but does not mediate...
Share
Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors - Journal of Cardiovascular Translational Research
Source : https://link.springer.com/article/10.1007/s12265-023-10379-5
Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent one type of new-generation type 2 diabetes (T2DM) drug treatment. The mechanism of action of an SGLT2 inhibitor (SGLT2i) in treating T2DM depends on...
Conclusions/Relevance: In this review, we summarize the animal models constructed to study the cardioprotective mechanisms of SGLT2is to help deliver a more comprehensive understanding of the in vivo work that has been done in this field and to help select the most optimal animal model to use when studying the different cardioprotective...
Share